Agene encoding sannamycin B-glycyltransferase (smsl3) of Streptomyces sannanensis IFO 14239 was identified by cloning and complementation of S. sannanensis mutant SN13 which is blocked at the interconversion of sannamycins B and A. The cloned DNAfragment also permitted the conversion of fortimicin B to A both in S. sannanensis SN13 and Streptomyces lividans TK23.
CLONING AND ANALYSIS OF A GENE (SMS13)
(dactimicin), Streptomyces tenjimariensis ATCC3 1 603 (istamycin), and Saccharopolyspora hirsuta ATCC20501 (sporaricin). This suggests that these genes of similar function from different genera were derived from a commonancestral gene.
Antibiotics with similar structures are often produced by taxonomically distant microorganisms, and the sequences of such antibiotic biosynthetic genes are well conserved, e.g. in polyketide antibiotics1* and in /Mactam antibiotics2~5); this is of considerable interest from the point of view of the evolution The biosynthetic pathway of fortimicin A in M. olivasterospora is believed to consist of more than 14 steps12). All members of the fortimicin-group antibiotics are thought to be synthesized by related biosynthetic pathways13 '14) . It is unlikely that such complex biosynthetic routes evolved by chance independently in different genera, and dissemination of these antibiotic productivities by some form of the horizontal transfer could be considered. We have previously reported a self-cloning system in S. sannanensis15) and also obtained nonproducing mutants by mutagenesis16). In this study, we cloned the sannamycin B-glycyltransferase gene by complementation in the nonproducing mutant S. sannanensis SN13, which was blocked at the conversion^sannamycin B to A (Fig. 1) . A study of the distribution of sequences similar to smsl3 in other actinomycetes is presented.
Materials and Methods
Bacterial Strains and Plasmids S. sannanensis IFO 14239 DNAwas used for the construction of a gene library in the shotgun-cloning of smsl3. S. sannanensis SN13, blocked at sannamycin B-glycyltransferase step16), was used as a host. S. lividans TK23 was employed to assay the fortimicin B to A converting activity by smsl3. Either Bacillus subtilis ATCC6633 or Escherichia coli ATCC26 were used as indicators for antibacterial activity. Plasmid pEN101 17) was used as a plasmid vector for S. sannanensis cloning. (Boehringer or Takara) were used under the conditions specified by the suppliers.
Cultivation
Shotgun-cloning and Subcloning of smsl3 Total DNA(300fig) prepared from S. sannanensis IFO 14239 was partially digested with Sau3A I and size-fractionated by 10~40%sucrose density gradient ultracentrifugation to obtain 4~6kb DNA fragments. Plasmid pENlOl prepared from S. sannanensis (10 fig) was completely digested with Bgl II and dephosphorylated with calf intestine alkaline phosphatase. The digested genomic DNA(22 fig) and vector DNA(10fig) were ligated with T4 DNAligase at 16°C for 15 hours and transformed into S. sannanensis SN13as described above. Thiopeptin-resistant transformants were incubated at 30°C for 6 days in SA mediumcontaining 2/ig/ml of thiopeptin, and the colonies were overlaid with E medium16)containing 105cells/ml of E. coli ATCC26 and incubated at 37°C for 16hours. Transformants which formed inhibitory zones were transferred to SY2 medium16) containing 50 /xg/ml of fortimicin A and incubated at 30°C for 3 days to eliminate E. coli.
Plasmid pSN13-l, obtained in the shotgun-cloning, was completely digested with EcoR I, and dephosphorylated with alkaline phosphatase. Subsequently, it was partially digested with Sau3A I and ligated with pENlOl cut by Bgl II. S. sannanensis SN13 was transformed with this DNAand the transformants restoring sannamycin A production were obtained. Plasmid containing insertion fragments smaller than that of pSN13-l were selected.
Construction of pSN1 3-l-8T Carrying smsl3 and a Fortimicin-resistance Gene A scheme for the formation of pSN13-l-8T carrying both smsl3 and a fortimicin-resistance gene was shown in Fig. 2 . Plasmid pSN13-l-8 which was obtained by subcloning was partially digested with Bell and ligated to the 1.5kb BamHI fragment of pFMRT320)containing the fortimicin A-resistance gene (fmrT) cloned from S. tenjimariensis ATCC31603. S. lividans TK23 was transformed with this DNA preparation. Thiopeptin-resistant transformants were transferred onto ATCCNo. 5 mediumcontaining neomycin B at SO^g/ml to select the transformants harboring fmrT. S. lividans TK23 (pSN13-l-8T) carrying both smsl3 and fmrT was selected from these transformants by determination of the physical Detection of Fortimicin B to Fortimicin A Converting Activity JULY 1992 Activity of sannamycin B-glycyltransferase in the washed mycelia was examined using fortimicin B as substrate according to Dairi and Hasegawa13) . The products were detected by HPLC13).
Alkaline Treatment of the Bioconversion Products of Fortimicin B The fortimicin B-bioconverted products by the washed mycelia of S. lividans TK23 (pSN13-l-8T) were treated in 0.16m NH4OHor 0.16n NaOHat room temperature for an hour and analyzed by using HPLCafter neutrization with H2SO4.
Southern-blot Hybridization Total DNAsisolated from various actinomycetes were digested with BamHI and separated in 0.7% agarose gel electrophoresis.
They were blotted to Genescreen plus (NEN) by the alkaline transfer method21*. The 0.8kb Sail fragment of pSN13-l was labeled with a-32P-dCTP (Amersham) by nick-translation. Hybridization was performed at 65°C for 16 hours in a hybridization solution consisting of 6 x SSC22), 5 x Denhardt's solution22), 100 //g/ml sonicated and denatured calf thymus DNA, with the radioactive DNAprobe. Filters were washed twice at room temperature in 150ml of 0.5 x SSC-0.2% SDS for 15minutes, and four times at 65°C in 250ml of0.3 x SSC-0.2% SDS for 30minutes. After drying, the filters were exposed to X-ray film (Fuji) at -80°C for 1~2 days.
Results
Cloning of smsl3 Glycylation of fortimicin B and sannamycin B (Fig. 1 ) are required to convert these antibiotics to biologically active molecules6). This amino acid transfer is an interesting characteristic of the biosynthesis of the fortimicin-group antibiotics. Wehave obtained the gene encoding the enzyme for this step by using S. sannanensis SN13, a mutant deficient in sannamycin B-glycyltransferase, as the host for cloning. Two transformants which restored antibiotic production were obtained from 6,126 thiopeptin-resistant transformants. These plasmids were designated pSN13-l and pSN13-2, respectively (Fig. 3 a) . A 2.7kb
overlapping region was observed in the inserts of the two plasmids. On subsequent subcloning, we obtained three types of plasmids from pSN13-l. Physical maps of their DNAinserts are shown in Fig.  3b . Plasmid pSN13-l-8 contained a minimum1.3kb fragment which was commonto the inserts of pSN13-l and pSN13-2; S. sannanensis SN13 (pSN13-l-8) restored sannamycin A production. Thus, smsl3 could be located within this 1.3kb. Fortimicin B to A converting activity was restored in the bioconversion using the washed mycelia of S. sannanensis SN13(pSN13-l) (Fig. 4, a~c) . Activity was also detected in the washed mycelia of S. lividans TK23 (pSN13-l-8T) harboring smsl3 together with the fortimicin-resistance gene (fmrT)20) of S. tenjimariensis ATCC31603 (Fig. 4, d~e) . We also observed an unknownproduct at a retention time very close to that of Af-formimidoylfortimicin A during HPLC analysis of the bioconverted products by S. lividans TK23 (pSN13-l-8T). However, it was not N-formimidoylfortimicin A because the peak was stable to alkaline treatment under conditions in which AT-formimidoylfortimicin A was degradated to fortimicin A (Fig. 4 f) . Thus, we concluded that the smsl3 gene product converted fortimicin B directly to fotimicin A.
Distribution of smsl3-\ike Sequences in Actinomycetes Southern-blot analysis was performed using the 0.8kb Sail fragment of pSN18-l-8 (Fig. 3 b) as a probe. Two signals, 0.8 and 0.55 kb, were detected in BamHI-digested S. sannanensis DNAin agreement with the structure of pSN13-l and pSN13-2 (Fig. 5) . Positive signals of different size (0.6 to 6.0kb) were detected in all the producers of fortimicin-group antibiotics. DNAhomologous to smsl3 detected in M. olivasterospora is present in the gene cluster for fortimicin biosynthesis (Dairi et al.\ in preparation) . The size of the DNAfragment detected in M. olivasterospora (6.0kb BamHI fragment) agreed with the organization of the gene cluster, which might encode fortimicin B-glycyltransferase (fins13). Analyses in which the genomic DNAswere digested with several restriction enzymes revealed significant conservation between M. olivasterospora and Micromonospora sp. SF-2098, independently isolated (data not shown). Under the hybridization-washing condition employedin this study, signals were detected in somestrains of Micromonospora and Dactylosporangium, i.e. M. purpurea ATCC15835 and M. echinospora subsp. echinospora ATCC15837 both of which produced gentamicins, M. zionensis IFO 141 16 which produced sisomicin, and D. aurantiacum ATCC23491.
Discussion
We have cloned a DNA fragment encoding sannamycin B-glycyltransferase (sms!3) using the self-cloning system of S. sannanensis. In both S. sannanensis and S. lividans carrying smsl3, fortimicin B was efficiently converted to fortimicin A in spite of difference in structures between sannamycin B and fortimicin B. This agrees with the result of bioconversion studies using the washed mycelia of S. sannanensis13). Bioconversion of fortimicin B using S. lividans TK23 (pSN13-l-8T) confirmed that the cloned DNA fragments contained the structural gene of sannamycin B-glycyltransferase and not a regulatory gene.
Twodifferent pathways have been postulated for the final stage of the biosynthesis of fotimicin A. In one, the final product, N-formimidoylfortimicin A, is directly synthesized from fortimicin B by addition of 7V-formimidoylglycine, and that fortimicin A is produced by a non-enzymatical decomposition of AT-formimidoylfortimicin A14). The other is that fortimicin A is synthesized from fortimicin B by addition of one molecule of glycine, and consequently Af-formimidoylfortimicin A is synthesized by addition of a formimidoyl group to the glycine moiety of fortimicin A23). Our results show the presence of a glycyltransferase directly converting fortimicin B to A in S. sannanensis; no activity converting fortimicin B to N-formimidoylfortimicin A was detected in S. lividans TK23 (pSN13-l-8T). The DNAfragment hybridizing with the smsl3 probe identified within the gene cluster for fortimicin A biosynthesis in M. olivasterospora (Dairi et al.; in preparation) must encode fortimicin B-glycyltransferase. These results support the notion that the final steps of fortimicin A biosynthesis are fortimicin B ->fortimicin A -> A^formimidoylfortimicin A. Sequences hybridizing to a DNAprobe derived from the smsl3 gene were found in all six producers of the fortimicin-group antibiotics. They are likely to be genes similar to that for sannamycin B-glycyltransferase responsible for glycine transfer to their corresponding precursors. This suggests that the sequences of the glycyltransferases are conserved amongthe producers of the fortimicin-group antibiotics. With respect to the commonbiosynthetic steps between M. olivasterospora and S. sannanensis and the sequence conservation of the biosynthetic genes amongthe producers of the fortimicin-group antibiotics13), the biosynthetic genes might have evolved from a commonset of ancestral genes and propagated beyond the genera. In DNAhybridization studies using smsl3, faint signals were detected in strains which produced the other aminoglycoside antibiotics, such as gentamicins and sisomicin. These signals could be due to similarity with smsl3 or its flanking sequences. These strains are not knownto produce any of the fortimicin-group antibiotics.
Considering the structures of gentamicins and sisomicin, glycyltransferase activity would not be involved in their biosynthesis. This suggests that they have silent glycyltransferase genes which are not expressed under laboratory conditions, or that there may be some sequence relationships within the biosynthetic genes for aminoglycoside antibiotics.
Further work is needed to determine the sequences of these related genes and the functions of the gene products.
